{"id":"W2077304538","doi":"10.1081/cnv-120014886","title":"The New Bisphosphonate, Zometa<sup>®</sup>(Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate","year":2002,"lang":"en","type":"review","venue":"Cancer Investigation","topic":"Bone health and treatments","field":"Medicine","cited_by":175,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Placebo; Breast cancer; Bisphosphonate; Prostate cancer; Chemotherapy; Internal medicine; Clinical endpoint; Urology; Hormonal therapy; Metastatic breast cancer; Surgery; Oncology; Gastroenterology; Cancer; Clinical trial; Osteoporosis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000199533,0.0005551626,0.001413827,0.0003499671,0.0003350978,0.00007976204,0.0002018819,0.0002818995,0.00006215526],"category_scores_gemma":[0.0003251722,0.0003973762,0.000180954,0.001113402,0.0002374523,0.0001163063,0.00008412748,0.0005722772,0.0001933427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009863133,"about_ca_system_score_gemma":0.001875204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001816676,"about_ca_topic_score_gemma":0.001360353,"domain_scores_codex":[0.9970483,0.0001959481,0.001095726,0.0006958186,0.0003738531,0.0005903788],"domain_scores_gemma":[0.9974082,0.0004986584,0.0004209062,0.000601451,0.00008675928,0.0009840585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002513905,0.00008004499,0.001224716,0.003387968,0.0001480293,0.00000964584,0.0002955488,0.0000698579,8.577245e-7,0.0001839268,0.004106377,0.9904679],"study_design_scores_gemma":[0.001819808,0.0003510033,0.00731328,0.02031361,0.001666885,0.0001028117,0.00006398236,0.00195374,0.000007343675,0.0003002083,0.9656212,0.0004861488],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002667775,0.9918261,0.00003596571,0.001759977,0.0001381587,0.003294388,0.0000710318,0.00008345117,0.0001231093],"genre_scores_gemma":[0.006697057,0.9881282,0.0004097083,0.0006993665,0.00007247837,0.002322789,0.000341203,0.00008922828,0.001239957],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9899817,"threshold_uncertainty_score":0.9998478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08590388979322759,"score_gpt":0.370019011997991,"score_spread":0.2841151222047634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}